Equity Analysis

Quarterly Results

    Vista Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524711
    INE427C01021
    11.2516323
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    0
    42.7
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    2
    0
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2024Sep 2024Jun 2024
Gross Sales2.562.491.80
Other Operating Income0.000.000.00
Other Income 0.120.010.07
Total Income2.682.501.87
Total Expenditure 4.073.322.57
PBIDT-1.39-0.82-0.71
Interest 0.220.250.28
PBDT-1.62-1.07-0.99
Depreciation0.190.180.18
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.48-0.28-0.31
Reported Profit After Tax-1.32-0.97-0.86
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-1.32-0.97-0.86
EPS (Unit Curr.)-0.07-0.16-0.15
EPS (Adj) (Unit Curr.)-0.07-0.16-0.15
Calculated EPS (Unit Curr.)-0.21-0.16-0.14
Calculated EPS (Adj) (Unit Curr.)-0.21-0.16-0.14
Calculated EPS (Ann.) (Unit Curr.)-0.86-0.63-0.56
Calculated EPS (Adj) (Ann.) (Unit Curr.)-0.86-0.63-0.56
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity12.3112.3112.31
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)-54.30-32.93-39.44
PBDTM(%)-63.28-42.97-55.00
PATM(%)-51.56-38.96-47.78
Dividend Per Share(Rs)0.000.000.00
Diluted EPS-0.07-0.17-0.15